A detailed history of Bogart Wealth, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Bogart Wealth, LLC holds 71 shares of IONS stock, worth $2,511. This represents 0.0% of its overall portfolio holdings.

Number of Shares
71
Previous 85 16.47%
Holding current value
$2,511
Previous $4,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$40.06 - $51.86 $560 - $726
-14 Reduced 16.47%
71 $2,000
Q2 2022

Jul 22, 2022

BUY
$31.71 - $43.0 $1,744 - $2,365
55 Added 183.33%
85 $3,000
Q1 2022

Apr 22, 2022

SELL
$29.88 - $37.04 $2,091 - $2,592
-70 Reduced 70.0%
30 $1,000
Q4 2021

Jan 19, 2022

SELL
$25.61 - $35.1 $640 - $877
-25 Reduced 20.0%
100 $3,000
Q1 2021

Apr 16, 2021

BUY
$42.51 - $63.78 $4,251 - $6,378
100 Added 400.0%
125 $6,000
Q4 2020

Jan 14, 2021

BUY
$45.3 - $60.27 $1,132 - $1,506
25 New
25 $1,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.02B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Bogart Wealth, LLC Portfolio

Follow Bogart Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bogart Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bogart Wealth, LLC with notifications on news.